{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:23:10Z","timestamp":1765610590942,"version":"3.45.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:00:00Z","timestamp":1793318400000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.resinv.2025.10.013","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:34:12Z","timestamp":1761845652000},"page":"1306-1308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug-induced autoimmune thyroiditis during lorlatinib treatment in a patient with ALK-positive non-small cell lung cancer"],"prefix":"10.1016","volume":"63","author":[{"given":"Yuki","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7407-4243","authenticated-orcid":false,"given":"Yuko","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6269-0586","authenticated-orcid":false,"given":"Yuka","family":"Aida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7737-9392","authenticated-orcid":false,"given":"Kazufumi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Hizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2025.10.013_bib1","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1200\/JCO.24.00581","article-title":"Lorlatinib versus crizotinib in patients with advanced ALK-positive non-small cell lung cancer: 5-year outcomes from the phase III CROWN study","volume":"42","author":"Solomon","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2025.10.013_bib2","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/thy.2015.0170","article-title":"Thyroid dysfunction in patients with metastatic carcinoma treated with sunitinib: is thyroid autoimmunity involved?","volume":"25","author":"Pani","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.resinv.2025.10.013_bib3","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1530\/EJE-14-0198","article-title":"Endocrine side-effects of anti-cancer drugs: thyroid effects of tyrosine kinase inhibitors","volume":"171","author":"Illouz","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.resinv.2025.10.013_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40618-021-01613-5","article-title":"Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors","volume":"45","author":"Rodia","year":"2022","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.resinv.2025.10.013_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.lungcan.2020.11.007","article-title":"Thyroid dysfunction in non-small cell lung cancer patients treated with epidermal growth factor receptor and anaplastic lymphoma kinase inhibitors: results of a prospective cohort","volume":"151","author":"Soni","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2025.10.013_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000039928","article-title":"Autoimmune complications of tyrosine kinase inhibitors in cancer therapy: clinical insights, mechanisms, and future perspectives","volume":"103","author":"Shi","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.resinv.2025.10.013_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/10781552231171322","article-title":"Brigatinib-associated autoimmune hepatitis: a case report","author":"Buyuksimsek","year":"2023","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.resinv.2025.10.013_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2169\/internalmedicine.4241-19","article-title":"Alectinib-induced immune hemolytic anemia in a patient with lung adenocarcinoma","volume":"60","author":"Okumoto","year":"2021","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2025.10.013_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2018.06.024","article-title":"New onset myasthenia gravis in a patient with non small cell lung cancer treated with lorlatinib a novel anti-cancer agent","volume":"392","author":"Desai","year":"2018","journal-title":"J Neurol Sci"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:03:31Z","timestamp":1763625811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534525001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2212534525001728"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2025.10.013","relation":{},"ISSN":["2212-5345"],"issn-type":[{"type":"print","value":"2212-5345"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced autoimmune thyroiditis during lorlatinib treatment in a patient with ALK-positive non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2025.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}]}}